• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ERIKA DE REYNOSA, S.A. DE C.V. LIBERTY CYCLER SET, DUAL PATIENT CONNECT; SYSTEM, PERITONEAL, AUTOMATIC DELIVERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ERIKA DE REYNOSA, S.A. DE C.V. LIBERTY CYCLER SET, DUAL PATIENT CONNECT; SYSTEM, PERITONEAL, AUTOMATIC DELIVERY Back to Search Results
Catalog Number 050-87212
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Fever (1858); Peritonitis (2252)
Event Date 04/06/2019
Event Type  Injury  
Manufacturer Narrative
Clinical investigation: a temporal relationship exists between ccpd therapy utilizing the liberty select cycler/liberty cycler set and the adverse event(s) of abdominal pain, cloudy effluent and fever which warranted hospitalization and initiation of antibiotic treatment.Based on the information available, the cause of the patient's streptococcus mitis peritonitis is unknown.However, there is no allegation nor any objective evidence indicating the patient¿s liberty select cycler and/or liberty cycler set caused or contributed to the patient's event of peritonitis.Peritonitis is a well-known potential complication in patients utilizing pd therapy.Streptococcus mitis is a known colonizer of the human oropharynx and gastrointestinal tract.The entry pathway of this bacterium into the peritoneal cavity can include contamination during the exchange procedure, gastrointestinal bacterial translocation, and hematological dissemination with oral and dental procedures as well as catheter contamination.
 
Event Description
On (b)(6) 2019, this (b)(6) female patient with end stage renal disease (esrd) on continuous cyclic peritoneal dialysis (ccpd) for renal replacement therapy (rrt) was reported to have developed peritonitis.There were no reported liberty select cycler/liberty cycler set product(s) issues or malfunctions reported during this initial call.Upon follow-up, the peritoneal dialysis registered nurse (pdrn) reported the patient was hospitalized on (b)(6) 2019 for abdominal pain, cloudy pd effluent, and fever.A sample of pd effluent was obtained for culture and cell count and the patient was prophylactically treated for suspected peritonitis with intraperitoneal (ip) vancomycin (1.9 gram), and ceftazidime (1.9 g gram) times one dose.The pdrn also reported, the patient was discharged to their home on (b)(6) 2019.The pdrn stated on (b)(6) 2019, the patient¿s pd effluent cultures yielded growth of streptococcus mitis, confirming a diagnosis of peritonitis.Cell count was not available.Per the pdrn, the patient was started on and is currently completing a 28-day course of vancomycin, 0.5 gram via ip dwell every 4 days.The pdrn also reported the cause of peritonitis is unknown.Additionally, the pdrn states the patient denied experiencing any fluid leaks liberty select cycler/liberty cycler set product issues or malfunctions related to this event; and the patient is recovering and continues pd treatment without further reported issues.
 
Manufacturer Narrative
Correction: outcomes attributed to adverse event: - removed life threatening.Patient codes.
 
Manufacturer Narrative
Plant investigation: the sample was not returned to the manufacturer and the lot number was not provided.A manufacturing review was performed on the products shipped to the patient for the three (3) month time frame which immediately preceded the event occurrence date.This review included the lot numbers for all fresenius liberty cycler sets shipped to this account within the selected time frame.The entire set of lots have been sold and distributed.There were no non-conformance's or abnormalities identified during the manufacturing process which could be associated with the reported event.An investigation of the device history records (dhr) was conducted and confirmed that the results of the in-progress and final quality control (qc) testing met all requirements.The product lots involved met all specifications for release.A review of the dhr did not reveal a probable cause for the customer complaint.As a physical evaluation could not be performed, a definitive conclusion regarding the reported incident could not be reached and a cause could not be confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIBERTY CYCLER SET, DUAL PATIENT CONNECT
Type of Device
SYSTEM, PERITONEAL, AUTOMATIC DELIVERY
Manufacturer (Section D)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa 88780
MX  88780
MDR Report Key8551663
MDR Text Key143223008
Report Number8030665-2019-00638
Device Sequence Number1
Product Code FKX
UDI-Device Identifier00840861100736
UDI-Public00840861100736
Combination Product (y/n)N
PMA/PMN Number
K043363
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Type of Report Initial,Followup,Followup
Report Date 05/02/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/25/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue Number050-87212
Was Device Available for Evaluation? No
Device Age MO
Date Manufacturer Received04/29/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
DELFLEX PD FLUID; LIBERTY SELECT CYCLER
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age51 YR
Patient Weight93
-
-